Speaker:
Michael Borowitz, MD, PhD, Johns Hopkins University
At the conclusion of this activity, learners should be able to:
* Describe how ALL classification has evolved over the last 50 years
* Compare and contrast methods for detection of minimal residual disease MRD in ALL
* Describe how MRD has been used in the management of patients with B-ALL
* describe how the use of anti-CD19 therapy has affected the outcome of patients with B-ALL
Current Topics in Pathology 2024